EODData

MEMBERSHIP REGISTER LOG IN

FRA, OFK: Orion Oyj

07 Nov 2025
LAST:

57.30

CHANGE:
 0.20		OPEN:
57.45		HIGH:
57.45		ASK:
0.00		VOLUME:
157
CHG(%):
0.35		PREV:
57.50		LOW:
57.30		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 2557.4557.4557.3057.30157
06 Nov 2557.8558.0056.9557.50157
05 Nov 2558.6558.6558.4058.40112
04 Nov 2559.3559.3559.3559.35540
03 Nov 2560.4060.4560.0060.00540
31 Oct 2561.1061.1060.4560.45117
30 Oct 2562.4062.4061.2061.20117
29 Oct 2560.7562.4060.7562.40117
28 Oct 2567.9570.0060.7560.75117
27 Oct 2568.6068.6068.1068.1070

COMPANY PROFILE

Name:Orion Oyj
About:Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Trexan for rheumatoid arthritis and cancer; and Dexdor, Precedex, and Dexmedetomidine products for human use. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other companies. It has discovery service and commercial license agreement with Invenra to develop bispecific antibody cancer therapeutics; and collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.
Sector:Healthcare
Address:Orionintie 1A, Espo, Finland, 02200
Website:https://www.orionpharma.com
ISIN:FI0009014377
LEI:74370029VAHCXDR7B745

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:26.61 
Forward P/E:29.41 
PEG Ratio:0.45 
Price to Sales:5.18 
Price to Book:8.19 
Profit Margin:0.19 
Operating Margin:0.29 
Return on Assets:0.13 
Return on Equity:0.32 
DivYield:0.02 
Div/Share:1.64 
Revenue:1.629B 
EBITDA:477.3M 
Shares:108.72M 
Market Cap:6.23B 

TECHNICAL INDICATORS

MA5:58.512.1%
MA10:60.555.7%
MA20:64.1311.9%
MA50:65.7014.7%
MA100:66.3215.7%
MA200:60.695.9%
RSI14:18.10 
WPR14:-100.00 
MTM14:-9.65
ROC14:-0.14 
ATR:1.36 
Week High:61.106.6%
Week Low:56.950.6%
Month High:70.1022.3%
Month Low:56.955.9%
Year High:71.7625.2%
Year Low:41.6637.6%
Volatility:2.46 

RECENT DIVIDENDS

Date Amount
15 Oct 2025$0.82
04 Apr 2025$0.82
15 Oct 2024$0.81
21 Mar 2024$0.81
23 Mar 2023$1.60
24 Mar 2022$1.50
26 Mar 2021$1.50
07 May 2020$1.50
26 Mar 2020$1.50
27 Mar 2019$1.50